Home>HFIM News

Improving the Drug Development Pipeline for Mycobacteria

[Review]   Modelling Antibiotic Exposure in the Hollow Fibre Infection Model Maitra, A.; Solanki, P.;Sadouki, Z.; McHugh, T.D.;Kloprogge, F. Improving the Drug Development Pipeline for Mycobacteria: Modelling Antibiotic Exposure in the Hollow Fibre Infection Model. Antibiotics 2021, 10, 1515. https://doi.org/10.3390/antibiotics10121515 Mycobacterial infections are difficult to treat, requiring a combination of drugs and lengthy treatment times, [...]

By |2022-03-23T12:37:47+00:00December 20th, 2021|blog, HFIM News|0 Comments

Standard therapy of MAC pulmonary disease shows limited efficacy in HFIM

Standard therapy of Mycobacterium avium complex pulmonary disease shows limited efficacy in an open source hollow fibre system that simulates human plasma and epithelial lining fluid pharmacokinetics : Ruth MM. et al.; Clinical Microbiology and Infection 2021 [abstract] Note : Supplementary information provided with this publication about the practical aspects of the set-up is helpful [...]

By |2022-03-23T12:37:47+00:00October 17th, 2021|HFIM News|0 Comments
Go to Top